Study Shows Twice Weekly Etanercept (Enbrel) Clears Psoriasis Lesions More Quickly Than Once Weekly Treatment
Initial treatment with twice weekly etanercept (Enbrel), a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis and psoriatic arthritis, according to results from the PRESTA study reported recently in the British Medical Journal…
Also tagged Arthritis, British Medical Journal, Enbrel, Etanercept, Factor Antagonist, Initial Treatment, Psoriasis, Psoriasis Arthritis, Psoriatic Arthritis, Skin Lesions, Skin Treatment, Tumour Necrosis Factor
